Stem Cell Oversight Committee

The Stem Cell Oversight Committee reviews research applications involving human pluripotent stem cells that have been derived from and embryonic source and/or will be transferred into humans or non-human animals to ensure compliance with Chapter 12, Section F of the TCPS 2 (2018).

Terms of Reference
Stem cell research
Administrative resources


Bernard Thébaud, MD, PhD
Senior Scientist, OHRI & CHEO Research Institute
Neonatologist, The Ottawa Hospital and CHEO
Professor of Pediatrics, Univ. of Ottawa
Univ. of Ottawa Partnership Research Chair in Regenerative Medicine

Susan Babcock
Director, Research Ethics Office
University of Alberta

Myriam Hemberger
Professor in the Departments of Biochemistry & Molecular Biology and Medical Genetics, University of Calgary Program Director of the Precision Medicine & Disease Mechanisms program at the Alberta Children’s Hospital Research Institute (ACHRI)

Rosario Isasi
Research Assistant Professor
Dr. John T. Macdonald Foundation Department of Human Genetics
University of Miami Miller School of Medicine

Andrea Jurisicova
Investigator at Lunenfeld Tanenbaum Research Institute at Mount Sinai Hospital in Toronto and Associate Professor at the Departments of Obstetrics and Gynecology and Physiology at University of Toronto

Ubaka Ogbogu
Assistant Professor in the Faculties of Law and Pharmacy & Pharmaceutical Sciences and the Katz Research Fellow in Health Law and Science Policy at the University of Alberta

Denis Claude Roy, MD, FRCPC
Full professor of medicine, University of Montreal; Chief executive officer, CellCAN and Scientific director of the Centre of Excellence for Cellular Therapy at Montreal’s Maisonneuve-Rosemont Hospital

Jeremy Snyder
Faculty of Health Sciences
Simon Fraser University

Michael Strong
President, CIHR
Ex-officio, non-voting member

Date modified: